Cohance Lifesciences Limited
COHANCE
Rank in Stocks
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Share Price
$5.05
Last synced: 2026-10-19
Market Cap
$1.93B
Change (1 day)
-1.44%
Change (1 year)
-57.38%
Country
IN
Trade Cohance Lifesciences Limited (COHANCE)
Category
Healthcare
Number of shares outstanding for Cohance Lifesciences Limited (COHANCE)
Number of shares outstanding as of June 2025: 384.88M
According to Cohance Lifesciences Limited latest financial reports and stock price the company's current number of shares outstanding is 384.88M. At the end of March 2024 the company had 254.48M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Cohance Lifesciences Limited (COHANCE) from 2019 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 384.88M | 52.92% |
| 2025 | 251.68M | -1.10% |
| 2024 | 254.48M | -0.04% |
| 2023 | 254.57M | 0.00% |
| 2022 | 254.56M | 0.00% |
| 2021 | 254.57M | 0.00% |
| 2020 | 254.56M | 0.00% |
| 2019 | 254.56M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 523.40% |
IN
|
